Patent details

EP3150256 Title: COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR

Basic Information

Publication number:
EP3150256
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161850904
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF ANTI-CD20 ANTIBODY AND PI3 KINASE SELECTIVE INHIBITOR
French Title of Invention:
COMBINAISON D'ANTICORPS ANTI-CD20 ET INHIBITEUR SÉLECTIF PI3 KINASE
German Title of Invention:
KOMBINATION VON ANTI-CD20-ANTIKÖRPERN UND PI3-KINASESELEKTIVEM INHIBITOR
SPC Number:

Dates

Filing date:
01/11/2013
Grant date:
15/07/2020
EP Publication Date:
05/04/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/07/2020
EP B1 Publication Date:
15/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/11/2022
Expiration date:
01/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/07/2020
 
 

Name:
Laboratoire Français du Fractionnement et des Biotechnologies
Address:
3, avenue des Tropiques, ZA Courtaboeuf,, 91940 Les Ulis, France (FR)

Name:
Rhizen Pharmaceuticals S.A.
Address:
Fritz Courvoisier 40, 2300 La Chaux de Fonds, Switzerland (CH)

Name:
TG Therapeutics Inc.
Address:
2 Gransevoort Street, 9th Floor, New York, NY 10014, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
05/10/2020
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
Miskin, Hari
Address:
United States (US)

2

Name:
Sportelli, Peter
Address:
United States (US)

3

Name:
Weiss, Michael
Address:
United States (US)

4

Name:
Vakkalanka, Swaroop K.V.S
Address:
Switzerland (CH)

Priority

1

Priority Number:
4595CH2012
Priority Date:
02/11/2012
Priority Country:
India (IN)

2

Priority Number:
201361771812 P
Priority Date:
02/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; A61K 39/395; A61K 45/06; A61P 35/00; A61P 37/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202029
Publication date:
15/07/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
19/10/2021
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
05/10/2020 Outgoing Correspondence 1
05/10/2020 Power Of Attorney 4